Skip to main content
Clinical Trials/CTRI/2023/11/060372
CTRI/2023/11/060372Not yet recruitingPhase 3

Comparative efficacy of injectable platelet rich fibrin and triamcinolone acetonide in symptomatic oral lichen planus

PGIDS Rohtak0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1)Clinically symptomatic and histologically proven cases of oral lichen planus in accordance to WHO criteria.
  • 2)Patient who give written consent to participate in the study

Exclusion Criteria

  • )Patient under the age of 18 years.
  • 2)Histopathological signs of moderate to severe dysplasia.
  • 3)Patients with genital or cutaneous involvement.
  • 4)History of topical or systemic corticosteroids therapy within one month prior to recruitment.
  • 5)Allergic or contraindication to administration of injectable corticosteroids.
  • 6)Patients with Hb levels <9 gm/dl and platelet count < 1 lakh/dl.
  • 7)Patients with known hematological disease, chronic liver disease and psychiatric disorders.
  • 8)Smokers or chewable tobacco users.
  • 9)Patients with pregnancy or lactating mothers.

Investigators

Sponsor
PGIDS Rohtak

Similar Trials